Insulin or substitutes
Prescribed insulin and insulin substitutes for managing diabetes
Is insulin or substitutes CRA eligible in Canada?
Yes. Insulin and insulin substitutes are CRA-eligible medical expenses, but they qualify under different provisions of the Income Tax Act with different requirements:
- Insulin qualifies under paragraph 118.2(2)(k). It requires a prescription from a medical practitioner but does not require recording by a pharmacist.
- Insulin substitutes (such as insulin analogues like lispro, aspart, or glargine) qualify under paragraph 118.2(2)(n). They require both a prescription from a medical practitioner and recording by a pharmacist.
Both qualify for the Medical Expense Tax Credit (METC) and are reimbursable through a Health Spending Account (HSA).
What Qualifies
- Insulin prescribed by a physician for Type 1 or Type 2 diabetes (under paragraph 118.2(2)(k) — prescription required, pharmacist recording not required)
- Insulin substitutes and analogues prescribed by a physician and recorded by a pharmacist (under paragraph 118.2(2)(n) — both prescription and pharmacist recording required)
- Other prescribed insulin substitutes approved by Health Canada
What Does Not Qualify
- Insulin or insulin substitutes obtained without a prescription from a medical practitioner
- Insulin substitutes that were prescribed but not recorded by a pharmacist (since they fall under 118.2(2)(n), pharmacist recording is required)
- Over-the-counter blood sugar supplements or non-prescription products marketed for diabetes management
Frequently Asked Questions
Is insulin CRA eligible?
Yes, under paragraph 118.2(2)(k), provided it is prescribed by a medical practitioner. Insulin substitutes are separately eligible under paragraph 118.2(2)(n) but require both a prescription and recording by a pharmacist.
Can I claim insulin through my HSA?
Yes. Insulin and prescribed insulin substitutes are reimbursable through a Health Spending Account, provided the applicable requirements for each provision are met.
Source
Based on the CRA's official eligible medical expenses list and Income Tax Folio S1-F1-C1, "Oxygen, insulin and injections for pernicious anaemia".
This information is sourced from the Canada Revenue Agency's official Medical Expense Tax Credit (METC) reference guide (lines 33099 and 33199). This is not tax advice. For the most current rulings, consult the CRA directly or speak with a qualified tax professional.
Based on CRA data last updated 2026-01-20. Page last reviewed 2026-03-20.